The present invention relates to a compound of the general formula (1),wherein the pyranose ring is alpha-D-galac-topyranose,A is selected from (2), and (3) The compound of formula (1) is suitable foruse in a method for treating a disorder relatingto the binding of a galectin, such as galectin-3 to a ligand in a mammal, suchas a human Furthermore, the present invention concernsa method for treatment of a disorder relating to the binding of a galectin,such as galectin-3 to a ligand in a mammal, such as a human
